These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20641145)

  • 1. Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms.
    Afonso G; Scotto M; Renand A; Arvastsson J; Vassilieff D; Cilio CM; Mallone R
    J Immunol Methods; 2010 Jul; 359(1-2):28-36. PubMed ID: 20641145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.
    Smith JG; Liu X; Kaufhold RM; Clair J; Caulfield MJ
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):871-9. PubMed ID: 11527795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the timeframe between blood collection and interferon gamma release assay using T-Cell Xtend®.
    Bouwman JJ; Thijsen SF; Bossink AW
    J Infect; 2012 Feb; 64(2):197-203. PubMed ID: 22120115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of critical parameters in blood processing for the bovine interferon-gamma ELISPOT assay to detect Mycobacterium bovis infected cattle in India.
    Veerasami M; Moorthy L; Das D; Parthasarathy S; Chandran D; Lingala R; Srinivasan VA
    Vet Ital; 2011; 47(1):25-34. PubMed ID: 21240848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord blood T cells respond against the Melan-A/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells.
    Merindol N; Grenier AJ; Caty M; Charrier E; Duval A; Duval M; Champagne MA; Soudeyns H
    J Immunol; 2010 Jul; 185(2):856-66. PubMed ID: 20543110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VACUTAINER CPT and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples.
    Ruitenberg JJ; Mulder CB; Maino VC; Landay AL; Ghanekar SA
    BMC Immunol; 2006 May; 7():11. PubMed ID: 16725038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function.
    McKenna KC; Beatty KM; Vicetti Miguel R; Bilonick RA
    J Immunol Methods; 2009 Feb; 341(1-2):68-75. PubMed ID: 19041316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of T-cell epitopes using the IFN-gamma ELISPOT assay.
    Wulf M; Hoehn P; Trinder P
    Methods Mol Biol; 2009; 524():439-46. PubMed ID: 19377964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.
    Derby EG; Reddy V; Nelson EL; Kopp WC; Baseler MW; Dawson JR; Malyguine AM
    Cytokine; 2001 Jan; 13(2):85-90. PubMed ID: 11145847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
    Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF
    Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of interferon-gamma ELISPOT in monitoring immune responses in humans.
    Matijevic M; Urban RG
    Methods Mol Biol; 2005; 302():237-52. PubMed ID: 15937356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects.
    Nilsson C; Aboud S; Karlén K; Hejdeman B; Urassa W; Biberfeld G
    Clin Vaccine Immunol; 2008 Apr; 15(4):585-9. PubMed ID: 18287577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT.
    Lenders K; Ogunjimi B; Beutels P; Hens N; Van Damme P; Berneman ZN; Van Tendeloo VF; Smits EL
    J Immunol Methods; 2010 May; 357(1-2):51-4. PubMed ID: 20214906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.
    Godard B; Gazagne A; Gey A; Baptiste M; Vingert B; Pegaz-Fiornet B; Strompf L; Fridman WH; Glotz D; Tartour E
    Hum Immunol; 2004 Nov; 65(11):1307-18. PubMed ID: 15556681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring--even in hands of ELISPOT-inexperienced investigators.
    Zhang W; Caspell R; Karulin AY; Ahmad M; Haicheur N; Abdelsalam A; Johannesen K; Vignard V; Dudzik P; Georgakopoulou K; Mihaylova A; Silina K; Aptsiauri N; Adams V; Lehmann PV; McArdle S
    J Immunotoxicol; 2009 Dec; 6(4):227-34. PubMed ID: 19908941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
    Dean GA; LaVoy A; Burkhard MJ
    Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.
    Peterson AC; Harlin H; Gajewski TF
    J Clin Oncol; 2003 Jun; 21(12):2342-8. PubMed ID: 12805336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
    Scheibenbogen C; Lee KH; Mayer S; Stevanovic S; Moebius U; Herr W; Rammensee HG; Keilholz U
    Clin Cancer Res; 1997 Feb; 3(2):221-6. PubMed ID: 9815676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.